Skip to content
Search

Latest Stories

1 in 3 ethnic minorities need 3 or more GP visits for cancer diagnosis, new survey reveals

1 in 3 ethnic minorities need 3 or more GP visits for cancer diagnosis, new survey reveals
Currently, only 60 per cent of cancer diagnoses are taking place before the cancer has progressed

The latest findings from the National Cancer Patient Experience Survey 2022 by QualityWatch, a joint programme with the Nuffield Trust and the Health Foundation shed light on concerning disparities faced by ethnic minority communities in the UK healthcare system.

Despite strides in cancer care, the survey highlights persistent challenges in easy and equitable access to timely diagnosis and quality communication, particularly for individuals from Mixed, Black, or Asian backgrounds.


Key insights from the survey underscored that individuals from ethnic minority groups often require a higher number of interactions with healthcare professionals before receiving a cancer diagnosis.

Notably, one in three people from Mixed, Black, or Asian ethnicities needed three or more visits to a GP practice, compared to the average of one in five across the population.

These delays in diagnosis can have significant implications for treatment outcomes and overall patient experience.

Moreover, the survey revealed concerning trends regarding the quality of communication following a cancer diagnosis among ethnic minority patients.

A substantial proportion of patients from deprived areas reported feeling inadequately informed about the reasons for their referrals and faced challenges in fully understanding their diagnosis.

Moreover, the analysis suggested that people from the most deprived populations in England were 21 per cent less likely to be referred for urgent suspected cancer than those from areas with low levels of deprivation.

This highlights systemic barriers in effective patient-provider communication, which are critical for informed decision-making and navigating the complexities of cancer care.

Dr. Liz Fisher, Senior Fellow at the Nuffield Trust, emphasized the urgency of addressing these disparities, noting that early diagnosis is pivotal for improving cancer survival rates.

"Detecting cancer early is vital to improving survival rates, for example, the rate of survival for bowel cancer drops significantly from 80 per cent if caught in stage 2 to 11 per cent at stage four."

She emphasised the need to enhance primary care capacity and provide tailored support for ethnic minority communities as essential to ensure equitable access to timely diagnosis and support services.

Tim Gardner, Assistant Director of Policy at the Health Foundation, echoed these sentiments, stressing the need for sustained investment in primary care to address underlying structural inequities in cancer care delivery.

He further suggested that by prioritizing culturally sensitive approaches and addressing communication barriers, healthcare providers can work towards narrowing the gap in cancer outcomes among most deprived populations.

The Nuffield Trust report also predicted higher chances of NHS missing its own target to have 75 per cent of cancers diagnosed at an early stage by 2028 as efforts to diagnose cancer at earlier stages has flatlined in recent years and currently, only 60 per cent of cancer diagnoses are taking place before the cancer has progressed.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less